LinkedIn
WebsiteIntroduction
ONEMEDNET CORP (Nasdaq: ONMD) is a public company headquartered in Eden Prairie, Minnesota, specializing in AI-powered Real-World Data (RWD) solutions. Established in 2006, the companyâs iRWD⢠platform provides de-identified, regulatory-grade clinical dataâfrom electronic health records and administrative claims to medical imagingâacross a growing network of healthcare and research institutions. By integrating advanced automation with human oversight, OneMedNet enables life sciences, medical device, and research organizations to access longitudinal patient records for testing, simulation, and real-world evidence generation.
Corporate Structure
OneMedNet employs between 11 and 50 professionals, including its executive leadership team:
- Dr. Jeffrey Yu, Vice President and Chief Medical Officer, a board-certified radiologist with fellowship training in nuclear medicine and the founder of the companyâs electronic imaging-sharing technology
- Bob Golden, Chief Financial Officer, a Certified Public Accountant with over 30 years of experience in corporate and tax advisory roles
- Steven Chartier, VP Engineering and Chief of Data, who has experience leading data integration and analytics platforms for clinical research organizations
The company trades under the ticker ONMD on the Nasdaq Capital Market. As of October 6, 2025, the stock closed at $1.56, reflecting a 51.46% increase on the day, with a trading volume of 2,555,433 shares.
Real-World Data by Luke Chesser
Recent Developments and News
On August 25, 2025, OneMedNet announced the addition of 85 cardiovascular centers to its RWD network, thereby expanding its data sources for post-market surveillance in cardiology. On August 13, 2025, the company filed a prospectus supplement (Rule 424(b)(3)) detailing a primary equity offering of up to 11,500,000 shares and a secondary offering of up to 28,152,560 shares.
Subsequently, on September 15, 2025, the company filed a Form 8-K under Item 8.01, reporting material strategic developments, including a long-term collaboration with Palantir Technologies to leverage Palantirâs AI platform for enhanced healthcare analytics. Additionally, the integration of its iRWD⢠platform with Datavant Connect powered by AWS Clean Rooms enables federated queries against imaging and EMR datasets from over 1,750 sites without data movement.
Financial and Strategic Analysis
According to Yahoo Finance, as of the trailing twelve months ended June 30, 2025, OneMedNet reported revenue of $459,000 and a net loss of $3.43 million, resulting in an EPS of â$0.10. The balance sheet shows $122,000 in cash and minimal debt. Market multiples indicate a Price/Sales ratio of 77.4 and an Enterprise Value/Revenue ratio of 101.6.
The Q2 2025 Form 10-Q filing (dated August 13, 2025) notes sequential revenue growth and positive cash flow from operations, attributed to increased subscription and curation services. The equity offerings announced in August 2025 are intended to support working capital and fund platform enhancements, aligning with the companyâs classification as an âemerging growth companyâ under SEC rules.
Market Position and Industry Context
OneMedNet operates within the expanding Real-World Data market, which serves drug developers, diagnostic AI firms, and health economics outcomes research teams. The company differentiates itself with longitudinal, multimodal datasetsâparticularly through the inclusion of medical imaging and clinical examsâoffered via a subscription model with ongoing updates. Strategic partnerships with healthcare systems, Palantir Technologies, and Datavant position the company within a collaborative framework focused on regulatory-grade evidence generation. While competitors in the space provide RWD services, OneMedNet's approach combines advanced AI de-identification, imaging integration, and continuous cohort updates.
tl;dr
On October 6, 2025, ONMD shares increased by 51.46% to $1.56, with heightened trading volume following announcements of partnerships and capital raises. The companyâs August 13, 2025, equity offerings and subsequent Form 8-K (September 15, 2025) illustrate its efforts to fund platform upgrades and expand its network, which now exceeds 1,750 sites. The integration with Datavant Connect and AWS Clean Rooms, alongside the collaboration with Palantir Technologies, emphasizes OneMedNetâs focus on secure access to longitudinal RWD. Future initiatives are expected to center on subscription growth, data curation services, and strategic alliances in the healthcare analytics market.
